Início › Cânceres do Sangue › Texas
Ensaios clínicos de Cânceres do Sangue em Texas
49 estudos para Cânceres do Sangue estão buscando participantes em locais em Texas.
Cidades em Texas
Texto oficial do estudo (Inglês)
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- Texas Oncology - Central/South Texas ( Site 8001), Austin
- Texas Oncology-Baylor Sammons Cancer Center ( Site 0062), Dallas
- University of Texas MD Anderson Cancer Center ( Site 0007), Houston
- e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT03486873Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- The Don and Sybil Harrington Cancer Center, Amarillo
- UT MD Anderson Cancer Center, Houston
- Audie L Murphy VA Hospital, San Antonio
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Texas Children's Hospital, Houston
RecrutandoEstudo observacional
Idades de 0 a 38 · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06131801A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
- MD Anderson Cancer Center - University of Texas, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07572006Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- UT Southwestern-Harold C. Simmons Cancer Center ( Site 2730), Dallas
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT04728893Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 6, Houston
RecrutandoFase 3
Idades de 18 a 71 · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07504458Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- e mais 2
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT03816345Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
- M D Anderson Cancer Center, Houston
RecrutandoFase 1 inicial
Idades de 12 a 80 · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT04744116Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- The University of Texas MD Anderson Cancer Center, Houston
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT07648264Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
- UT MD Anderson Cancer Center, Houston
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT07743476Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- The Don and Sybil Harrington Cancer Center, Amarillo
- Audie L Murphy VA Hospital, San Antonio
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT04242095Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
- Texas Children's Hospital, Houston
- The Methodist Hospital, Houston
RecrutandoFase 1
Até 75 anos · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT06345027(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- The University of Texas MD Anderson Cancer Center, Houston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT04996875A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- Md Anderson Cancer Center, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07195916Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
- M D Anderson Cancer Center, Houston
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT02464696Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- M D Anderson Cancer Center, Houston
RecrutandoFase 2Voluntários saudáveis bem-vindos
Todas as idades · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT04984551Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
- M D Anderson Cancer Center, Houston
RecrutandoFase 1
Todas as idades · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT03425526Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
- Baylor Scott & White Health, Dallas
- MD Anderson, Houston
RecrutandoFase 1/2
Idades 12 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT04588922Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- M D Anderson Cancer Center, Houston
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT01772771Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- Texas Oncology-Austin Midtown, Austin
- Texas Oncology-Presbyterian Cancer Center, Dallas
- University of Texas, Houston
- e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT07007312Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances
- M D Anderson Cancer Center, Houston
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT05110742Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
- MD Anderson Cancer Center, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT06001788Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
- M D Anderson Cancer Center, Houston
RecrutandoFase 1 inicial
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT06184321Expressive Writing for the Management of Stress in Cancer Survivors
- M D Anderson Cancer Center, Houston
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 14 de ago. de 2026 · NCT04776941The Impact of COVID-19 on Pulmonary Procedures
- M D Anderson Cancer Center, Houston
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Todas as idades · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT05022446Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies
- M D Anderson Cancer Center, Houston
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT05108519A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
- MD Anderson Cancer Center, Houston
- NEXT Oncology, Irving
- UT San Antonio Mays Cancer, San Antonio
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT06823167PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
- University of Texas MD Anderson MD Anderson Cancer Center, Houston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 4 de ago. de 2026 · NCT06665100A Study of APG-3288 in Relapsed/Refractory Blood Cancers
- The University of TX MD Anderson Cancer Center, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 30 de jul. de 2026 · NCT07424833Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
- M D Anderson Cancer Center, Houston
RecrutandoFase 2
Idades 12 e acima · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT04712539A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Medical City Dallas, Dallas
- Children's Medical Center Dallas, Dallas
- Zachary & Elizabeth Fisher Bone Marrow Transplant Program (Brooke Army Medical Center), Fort Sam Houston
- e mais 5
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT01351545Improving Comprehensive Care of Cancer Patients
- Baylor College of Medicine, Houston
RecrutandoVoluntários saudáveis bem-vindos
Idades 18 e acima · Todos os sexos · Atualizado em 30 de jun. de 2026 · NCT05323409Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
- UT Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 15 de jun. de 2026 · NCT02074839Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
- M D Anderson Cancer Center, Houston
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 12 de jun. de 2026 · NCT00991094The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors
- M D Anderson Cancer Center, Houston
RecrutandoEstudo observacional
Idades de 18 a 39 · Todos os sexos · Atualizado em 2 de jun. de 2026 · NCT04551378Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method
- M D Anderson Cancer Center, Houston
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades 21 e acima · Todos os sexos · Atualizado em 26 de mai. de 2026 · NCT05054413Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
- M D Anderson Cancer Center, Houston
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 20 de mai. de 2026 · NCT05011045Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients
- M D Anderson Cancer Center, Houston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT05529069A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
- Medical City Dallas Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- e mais 1
RecrutandoFase 3
Idades de 2 a 18 · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT05711667Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- MD Anderson Cancer Center, Houston
RecrutandoFase 1
Idades 13 e acima · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT04771572Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.